The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. December 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback